Nasus Pharma Ltd. (NSRX) Stock Forecast
Data as of May 3, 2026Healthcare · Current price $2.61 (-3.33%)
Consensus Target
$22.00
Upside
+742.9%
Analysts
1
Rating
Buy(2.00)
Price Target Range
Low $22.00High $22.00
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
Consensus
Buy
Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Sep 29, 2025 | Yale Jen | Laidlaw | $22.00 | +742.9% |
Top Analysts Covering NSRX
NSRX vs Sector & Market
| Metric | NSRX | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.24 | 2.41 |
| Analyst Count | 1 | 8 | 18 |
| Target Upside | +742.9% | +1149.3% | +14.9% |
| P/E Ratio | -17.21 | 6.88 | 31.19 |
Frequently Asked Questions
What is the analyst consensus for NSRX?
The consensus among 1 analysts covering Nasus Pharma Ltd. (NSRX) is Buy with an average price target of $22.00.
What is the highest price target for NSRX?
The highest price target for NSRX is $22.00, set by Yale Jen at Laidlaw on 2025-09-29.
What is the lowest price target for NSRX?
The lowest price target for NSRX is $22.00, set by Yale Jen at Laidlaw on 2025-09-29.
How many analysts cover NSRX?
1 analysts have issued ratings for Nasus Pharma Ltd. in the past 12 months.
Is NSRX a buy or sell right now?
Based on 1 analyst ratings, NSRX has a consensus rating of Buy (2.00/5) with a +742.9% upside to the consensus target of $22.00.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.